The National Institute for Health and Care Excellence (NICE) has issued draft final guidance in England and Wales recommending the use of avatrombopag (Doptelet, Sobi) in adults with primary chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback